Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension

Experimental Biology and Medicine

Volumn 240, Issue 9, 2015, Pages 1223-1234

  Wang, Youping ^a   Zhu, Mingjun ^a   Xu, Hui ^b   Cui, Lin ^a   Liu, Weihong ^a   Wang, Xiaoxiao ^a   Shen, Si ^a   Wang, Donna H ^b  

^a HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Chemokine receptor 2; Deoxycorticosterone acetate salt hypertension; Mice; Renal injury; Transient receptor potential vanilloid type 1 channel

Indexed keywords

8 ISOPROSTANE; ALBUMIN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR2 ANTAGONIST; COLLAGEN; CREATININE; CYTOKINE; DEOXYCORTICOSTERONE ACETATE; HYDROXYPROLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; VANILLOID RECEPTOR 1; BENZOXAZINE DERIVATIVE; CCL2 PROTEIN, MOUSE; CCR2 PROTEIN, MOUSE; RS 504393; SALT INTAKE; SPIRO COMPOUND; TRPV1 PROTEIN, MOUSE; VANILLOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BLOOD ANALYSIS; BODY WEIGHT; CHEMILUMINESCENCE IMMUNOASSAY; COLORIMETRY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULOSCLEROSIS; HYDROXYPROLINE ASSAY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY MASS; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SALT SENSITIVE HYPERTENSION; SYSTOLIC BLOOD PRESSURE; TUBULOINTERSTITIAL INJURY; UNINEPHRECTOMY; URINALYSIS; WESTERN BLOTTING; ADMINISTRATION AND DOSAGE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DEFICIENCY; DRUG EFFECTS; GENETICS; INJURIES; KIDNEY; KNOCKOUT MOUSE; METABOLISM; ORGAN SIZE; PATHOLOGY; SALT INTAKE; SIGNAL TRANSDUCTION;

ANIMALS; BENZOXAZINES; BODY WEIGHT; CHEMOKINE CCL2; DESOXYCORTICOSTERONE ACETATE; HYPERTENSION; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN SIZE; RECEPTORS, CCR2; SIGNAL TRANSDUCTION; SODIUM CHLORIDE, DIETARY; SPIRO COMPOUNDS; TRPV CATION CHANNELS;

EID: 84960396381     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370214565970     Document Type: Article

References (36)

1. Kusunoki H, Taniyama Y, Rakugi H, Morishita R. Cardiac and renal protective effects of irbesartan via peroxisome proliferator-activated receptorg-hepatocyte growth factor pathway independent of angiotensin II type 1a receptor blockade in mouse model of salt-sensitive hypertension. J Am Heart Assoc 2013;2:e000103
2. Wang Y, Wang DH. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension. Am J Physiol 2009;297:F1550–9
3. Zimmermann HW, Trautwein C, Tacke F. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol 2012;3:56–74.
4. Kitagawa K, Wada T, Furuichi K, Hashimoto H, Ishiwata Y, Asano M, Takeya M, Kuziel WA, Matsushima K, Mukaida N, Yokoyama H. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 2004;165:237–46
5. Elmarakby AA, Quigley JE, Olearczyk JJ, Sridhar A, Cook AK, Inscho EW, Pollock DM, Imig JD. Chemokine receptor 2b inhibition provides renal protection in angiotensin II-salt hypertension. Hypertension 2007;50:1069–76
6. Awad AS, Kinsey GR, Khutsishvili K, Gao T, Bolton WK, Okusa MD. Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury. Am J Physiol 2011;301:F1358–66
7. Wimalawansa SJ. Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr Rev 1996;17:533–85
8. Earley S. Vanilloid and melastatin transient receptor potential channels in vascular smooth muscle. Microcirculation 2010;17:237–49.
9. Ching LC, Kou YR, Shyue SK, Su KH, Wei J, Cheng LC, Yu YB, Pan CC, Lee TS. Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type1. Cardiovasc Res 2011;191:492–501
10. Poblete IM, Orliac ML, Briones R, Adler-Graschinsky E, Huidobro- Toro JP. Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed. J Physiol 2005;568:539–51
11. O’Neill J, Brock C, Olesen AE, Andresen T, Nilsson M, Dickenson AH. Unravelling the mystery of capsaicin: a tool to understand and treat pain. Pharmacol Rev 2012;64:939–71
12. Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature 2001;413:203–10
13. Yiangou Y, Facer P, Dyer NH, Chan CL, Knowles C, Williams NS, Anand P. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 2001;357:1338–9
14. Chan CL, Facer P, Davis JB, Smith GD, Egerton J, Bountra C, Williams NS, Anand P. Sensory fibers expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet 2003;361:385–91
15. Veronesi B, Carter JD, Devlin RB, Simon SA, Oortgiesen M. Neuropeptides and capsaicin stimulate the release of inflammatory cytokines in a human bronchial epithelial cell line. Neuropeptides 1999;33:447–56
16. Wang Y, Wang DH. Role of the transient receptor potential vanilloid type 1 channel in renal inflammation induced by lipopolysaccharide in mice. Am J Physiol 2013;304:R1–9
17. Huang W, Rubinstein J, Prieto AR, Thang LV, Wang DH. Transient receptor potential vanilloid gene deletion exacerbates inflammation and atypical cardiac remodeling after myocardial infarction. Hypertension 2009;53:243–50
18. Clark N, Keeble J, Fernandes ES, Starr A, Liang L, Sugden D, deWinter P, Brain SD. The transient receptor potential vanilloid (TRPV1) receptor protects against the onset of sepsis after endotoxin. FASEB J 2007;21:2747–3755
19. Helyes Z, Elekes K, Németh J, Pozsgai G, Sándor K, Kereskai L, Börzsei R, Pintér E, Szabó Á, Szolcsányi J. Role of transient receptor potential vanilloid 1 receptors in endotoxin-induced airway inflammation in the mouse. Am J Physiol Lung Cell Mol 2007;292:L1173–81
20. Furuichi K, Wada T, Iwata Y, Kitagawa K, Kobayashi K, Hashimoto H, Ishiwata Y, Asano M, Wang H, Matsushima K, Takeya M, Kuziel WA, Mukaida N, Yokoyama H. CC2 signaling contributes to ischemiareperfusion injury in kidney. J Am Soc Nephrol 2003;14:2503–15
21. Kitagawa K, Wada T, Furuichi K, Hashimoto H, Ishiwata Y, Asano M, Takeya M, Kuziel WA, Matsushima K, Mukaida N, Yokoyama H. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 2004;165:237–46.
22. Safar ME, London GM, Plante GE. Arterial stiffness and kidney function. Hypertension 2004;43:163–8
23. Feng M, Whitesall S, Zhang Y, Beibei M, D’Alecy L, DiPetrillo K. Validation of volume-pressure recording tail-cuff blood pressure measurements. Am J Hypertens 2008;21:1288–91
24. Wang Y, Wang DH. Role of substance P in renal injury during DOCAsalt hypertension. Endocrinology 2012;153:5972–9
25. Chiariello M, Ambrosio G, Cappelli-Biqazzi M, Perrone-Filardi P, Briqante F, Sifola C. A biochemical method for the quantitation of myocardial scarring after experimental coronary artery occlusion. J Mol Cell Cardiol 1986;18:283–90
26. Sayyed SG, Ryu M, Kulkarni OP, Schmid H, Lichtnekert J, Gruner S, Green L, Mattei P, Hartmann G, Anders HJ. An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. Kidney Int 2011;80:68–78
27. Eardley KS, Zehnder D, Quinkler M, Lepenies J, Bates RL, Savage CO, Howie AJ, Adu D, Cockwell P. The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int 2006;69:1189–97
28. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998;2:275–81
29. Ino K, Masuya M, Tawara I, Miyata E, Oda K, Nakamori Y, Suzuki K, Ohishi K, Katayama N. Monocytes infiltrate the pancreas via the MCP-1/CCR2 pathway and differentiate into stellate cells. PLoS One 2014;9:e84889
30. Ivashkiv LB. Inflammatory signaling in macrophages: transitions from acute to tolerant and alternative activation states. Eur J Immunol 2011;41:2477–81
31. Viedt C, Dechend R, Fei J, Hansch GM, Kreuzer J, Orth SR. MCP-1 induces inflammatory activation of human tubular epithelial cells. J Am Soc Nephrol 2002;13:1534–47
32. Jura J, Skalniak L, Koj A. Monocyte chemotactic protein-1- induced protein-1 (MCPIP1) is a novel multifunctional modulator of inflammatory reactions. Biochim Biophys Acta 2012;1823:1905–13
33. Franco-Penteado CF, De Souza IA, Camargo EA, Teixeira SA, Muscara MN, De Nucci G, Antunes E. Mechanisms involved in the enhancement of allergic airways neutrophil influx by permanent Cfiber degeneration in rats. J Pharmacol Exp Ther 2005;313:440–8
34. Shen B, Smith RS Jr, Hsu YT, Chao L, Chao J. Kruppel-like factor 4 is a novel mediator of Kallistatin in inhibiting endothelial inflammation via increased endothelial nitric-oxide synthase expression. J Biol Chem 2009;284:35471–8
35. Montecucco F, Pende A, Alessandra Q, Mach F. Inflammation in the pathophysiology of essential hypertension. J Nephrol 2011;24:23–34
36. Singh MV, Chapleau MW, Harwani SC, Abboud FM. The immune system and hypertension. Immunol Res 2014;59:243–53